| Company | Date | Position | Consensus β | Price Target β | 2-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
LQDA
Liquidia Technologies
|
Sep 30, 2026 | HOLD |
Strong Buy
+49.0% avg upside
15 analysts
|
β | +0.0% | Β· |
|
TECX
Tectonic Therapeutic
|
Sep 29, 2026 | BUY |
Strong Buy
+141.0% avg upside
24 analysts
|
$88.00
290.45% Upside
|
-3.4% | Β· |
|
CTNM
Contineum Therapeutics, Inc. Class A
|
Sep 29, 2026 | BUY |
Strong Buy
+63.2% avg upside
9 analysts
|
$23.00
75.29% Upside
|
+14.1% | Β· |
|
SION
Sionna Therapeutics, Inc.
|
Sep 19, 2026 | HOLD |
Buy
+329.1% avg upside
12 analysts
|
$6.00
22.30% Upside
|
-14.2% | Β· |
|
IKT
Inhibikase Therapeutics
|
Sep 15, 2026 | BUY |
Strong Buy
+200.7% avg upside
8 analysts
|
$5.00
150.10% Upside
|
-10.8% | Β· |
|
TENX
Tenax Therapeutics
|
Aug 10, 2026 | BUY |
Buy
+751.3% avg upside
9 analysts
|
$5.00
152.50% Upside
|
+44.0% | Β· |
|
CNTM
ConnectM Technology Solutions
|
Jul 30, 2026 | BUY |
Strong Buy
+427.6% avg upside
1 analyst
|
$24.00
427.55% Upside
|
-16.5% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.